173 related articles for article (PubMed ID: 9080472)
1. Radiopharmacokinetic data for 99mTc-ABP--a new radiopharmaceutical for bone scanning: comparison with 99mTc-MDP.
Arteaga de Murphy C; Meléndez-Alafort L; Montoya-Molina CE; Sepúlveda-Méndez J
Nucl Med Biol; 1997 Jan; 24(1):27-33. PubMed ID: 9080472
[TBL] [Abstract][Full Text] [Related]
2. [99m-Tc alendronate as a new option in bone gammagraphy].
Montoya-Molina CE; Sepúlveda-Méndez J; Arteaga-de-Murphy C; Meléndez-Alafort L; Rojas-Bautista JC; López-Alvarenga JC
Rev Invest Clin; 1997; 49(5):373-7. PubMed ID: 9527697
[TBL] [Abstract][Full Text] [Related]
3. [Radiopharmacokinetic and gammagraphic studies for calculating personalized dosimetry].
Arteaga de Murphy C; Pedraza-López M; Ferro-Flores G; Montoya-Molina CE; Meléndez-Alafort L
Rev Invest Clin; 2001; 53(3):228-34. PubMed ID: 11496710
[TBL] [Abstract][Full Text] [Related]
4. Technetium-99m-alendronate: a new radiopharmaceutical for bone scanning.
Arteaga de Murphy C; Meléndez-Alafort L; Montoya-Molina C; Sepúlveda-Méndez J
Arch Med Res; 1996; 27(4):481-3. PubMed ID: 8987181
[TBL] [Abstract][Full Text] [Related]
5. Labelling of Re-ABP with 188Re for bone pain palliation.
Arteaga de Murphy C; Ferro-Flores G; Pedraza-López M; Meléndez-Alafort L; Croft BY; Ramírez FM; Padilla J
Appl Radiat Isot; 2001 Mar; 54(3):435-42. PubMed ID: 11214878
[TBL] [Abstract][Full Text] [Related]
6. [A new radiopharmaceutical for bone imaging: experimental study of 99mTc-HEDTMP].
Hu S; Deng H; Jiang S; Luo S; Lei Y
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2010 Aug; 27(4):811-5. PubMed ID: 20842850
[TBL] [Abstract][Full Text] [Related]
7. Is (99m)Tc-labelled pamidronate a better agent than (99m)Tc-medronate for bone imaging?
Kumar V; Kumar D; Howman-Giles RB; Little DG
Nucl Med Commun; 2007 Feb; 28(2):101-7. PubMed ID: 17198350
[TBL] [Abstract][Full Text] [Related]
8. Validation of a blood-sampling method for the measurement of 99mTc-methylene diphosphonate skeletal plasma clearance.
Moore AE; Blake GM; Fogelman I
J Nucl Med; 2006 Apr; 47(4):581-6. PubMed ID: 16595490
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetic and imaging evaluation of (99m)Tc-HBIDP as a potential bone imaging agent.
Qiu L; Lin J; Nan B; Lv G; Cheng W
Pak J Pharm Sci; 2015 May; 28(3):815-8. PubMed ID: 26004712
[TBL] [Abstract][Full Text] [Related]
10. A study to determine the dependence of 99mTc-MDP protein binding on plasma clearance and serum albumin concentration.
Moore AE; Blake GM; Fogelman I
Nucl Med Commun; 2007 Mar; 28(3):187-92. PubMed ID: 17264777
[TBL] [Abstract][Full Text] [Related]
11. Determination of lesion to normal bone uptake ratios of skeletal radiopharmaceuticals by QARG (quantitative autoradiography).
Ghiron J; Volkert WA; Garlich J; Holmes RA
Int J Rad Appl Instrum B; 1991; 18(2):235-40. PubMed ID: 2026500
[TBL] [Abstract][Full Text] [Related]
12. Influence of the phosphate balance on the activity distribution of 99mTc-hydroxy-methylene diphosphonate. Experimental studies in the mouse.
Cronhjort M; Sääf M; Sjöberg HE; Schnell PO; Jacobsson H
Acta Radiol; 1998 Jul; 39(4):427-33. PubMed ID: 9685832
[TBL] [Abstract][Full Text] [Related]
13. A direct in vivo measurement of 99mTc-methylene diphosphonate protein binding.
Blake GM; Moore AE; Park-Holohan SJ; Fogelman I
Nucl Med Commun; 2003 Jul; 24(7):829-35. PubMed ID: 12813203
[TBL] [Abstract][Full Text] [Related]
14. New bone-seeking agent: animal study of Tc-99m-incadronate.
Shigematsu M; Shomi S; Iwao H; Ochi H
Ann Nucl Med; 2002 Feb; 16(1):55-9. PubMed ID: 11922209
[TBL] [Abstract][Full Text] [Related]
15. Correlation of 99mTc-sestamibi uptake with blood-pool and osseous phase 99mTc-MDP uptake in malignant bone and soft-tissue tumours.
Ozcan Z; Burak Z; Erinç R; Dirlik A; Başdemir G; Sabah D; Ozkiliç H
Nucl Med Commun; 2001 Jun; 22(6):679-83. PubMed ID: 11403180
[TBL] [Abstract][Full Text] [Related]
16. Extraosseous accumulation of bone scanning agents in malignant brain tumors: comparison to semi-quantitative evaluation with 99mTc SPECT/201Tl SPECT and histological findings.
Suzuki A; Togawa T; Kuyama J; Nakahara T; Iuchi T; Oga M; Osato K; Takenouchi T
Ann Nucl Med; 2003 Jul; 17(5):387-92. PubMed ID: 12971637
[TBL] [Abstract][Full Text] [Related]
17. Influence of whole-body vibration on biodistribution of the radiopharmaceutical [99mTc]methylene diphosphonate in Wistar rats.
Pereira Mde O; Pinto Nde S; Monteiro Mde O; Santos-Filho SD; Carmo FS; Diniz CL; Marin PJ; Bernardo-Filho M
Int J Radiat Biol; 2013 Aug; 89(8):668-72. PubMed ID: 22849312
[TBL] [Abstract][Full Text] [Related]
18. 99Tcm-DTPMP as a skeletal scintigraphy agent: distribution in rats in comparison with 99Tcm-MDP.
Láznícek M; Láznícková A; Budský F
Nucl Med Commun; 1996 Dec; 17(12):1016-20. PubMed ID: 9004296
[TBL] [Abstract][Full Text] [Related]
19. 99Tcm-citrate: a new bone imaging radiopharmaceutical.
Bhatnagar A; Mishra P; Sharma R; Chuttani K; Chakravarty K; Jain CM; Mondal A; Chopra MK; Gupta A
Nucl Med Commun; 1999 Nov; 20(11):1067-76. PubMed ID: 10572918
[TBL] [Abstract][Full Text] [Related]
20. Soft tissue uptake on 99mTc methylene diphosphonate bone scan imaging: pictorial review.
Kaye J; Hayward M
Australas Radiol; 2002 Mar; 46(1):13-21. PubMed ID: 11966582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
